Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
135.67
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jun 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
135.67
Bid (Size)
133.62 (1)
Ask (Size)
137.45 (1)
Prev. Close
135.67
Today's Range
135.67 - 135.67
52wk Range
120.40 - 158.34
Shares Outstanding
122,180,759
Dividend Yield
1.65%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
June 08, 2023
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a...
Via
Benzinga
Want Growing Passive Income? Consider Buying This Stock
May 24, 2023
This maker of diagnostics tests has delivered 13 years of dividend growth to shareholders.
Via
The Motley Fool
Performance
YTD
-12.90%
-12.90%
1 Month
+1.51%
+1.51%
3 Month
+0.58%
+0.58%
6 Month
-9.85%
-9.85%
1 Year
+0.09%
+0.09%
More News
Read More
Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds
May 18, 2023
Via
Benzinga
Exact Sciences Serves Investors Exactly What They Wished For
May 15, 2023
Via
MarketBeat
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
May 11, 2023
Via
Benzinga
The Latest Analyst Ratings for Quest Diagnostics
May 02, 2023
Via
Benzinga
Will Chart Analysts Notice Bad Omen on Quest Diagnostics's Chart
May 02, 2023
Via
Benzinga
Quest Diagnostics Q1 Earnings Surpass Expectations; COVID-19 Testing Revenues Slump 80%
April 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
May 02, 2023
Via
Benzinga
UiPath is a Cheaper and More Profitable AI Stock
April 06, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Analyst Expectations for Quest Diagnostics's Future
April 03, 2023
Via
Benzinga
Analyst Expectations for Quest Diagnostics's Future
March 17, 2023
Via
Benzinga
5 Analysts Have This to Say About Quest Diagnostics
January 23, 2023
Via
Benzinga
Analyst Ratings for Quest Diagnostics
January 06, 2023
Via
Benzinga
Where Quest Diagnostics Stands With Analysts
December 14, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session
March 24, 2023
Via
Investor Brand Network
Is This Healthcare Stock a Buy for Dividend Growth Investors?
March 07, 2023
Via
The Motley Fool
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%
February 15, 2023
Via
The Motley Fool
Golden Cross Appears Before Quest Diagnostics Investors
November 28, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
January 23, 2023
Via
Benzinga
Down 40% in 2022, Can Exact Sciences Recover in 2023?
January 23, 2023
Via
The Motley Fool
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades'
December 23, 2022
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.